VIVEbiotech announces significant growth in 2023
- Dec 18, 2023
- 1 min read
San Sebastián, Spain, December 14, 2023 - VIVEbiotech, S.L., a GMP contract development and manufacturing organization (CDMO) full specialized in lentiviral vectors (LVVs), today announced significant growth in 2023, with sales increasing by 70%.